$RFL SEC Filings

Filed On	Filing
27 Oct 2026	Form 4: Polinsky David, Chief Financial Officer Gave up 4,245 shares to cover exercise price or tax ($5.4K)
30 Sep 2026	8-K: Regulation FD Disclosure; Other Events Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
23 Sep 2026	Form 4: Polinsky David, Chief Financial Officer Gave up 2,027 shares to cover exercise price or tax ($4.1K)
31 Jul 2026	Form 4: Jonas Howard S, Director Received 54,945 shares as a grant or award ($150K)
08 Jul 2026	8-K: Regulation FD Disclosure
23 Jun 2026	Form 4: Polinsky David, Chief Financial Officer Gave up 2,386 shares to cover exercise price or tax ($6.29K)
16 Jun 2026	Form 4: Jonas Howard S, Director Gave up 8,786 shares to cover exercise price or tax ($20.5K) · Received 142,857 shares as a grant or award ($250K)
11 Jun 2026	QUARTERLY REPORT
11 Jun 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	8-K: Regulation FD Disclosure; Other Events
22 Apr 2026	8-K: Regulation FD Disclosure; Other Events
24 Mar 2026	Form 4: Polinsky David, Chief Financial Officer Gave up 2,318 shares to cover exercise price or tax ($2.96K)
17 Mar 2026	Form 4: Jonas Howard S, Director Gave up 9,826 shares to cover exercise price or tax ($14.8K)
16 Mar 2026	QUARTERLY REPORT
16 Mar 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	Form 4: Sieger Markus, Director Received 29,528 shares as a grant or award ($37.5K)
29 Jan 2026	Form 4: Weiss Michael J, Director Received 39,370 shares as a grant or award ($50K)
29 Jan 2026	Form 4: Stein Mark N, Director Received 39,370 shares as a grant or award ($50K)
29 Jan 2026	Form 4: Grayson Alan, Director Received 6,562 shares as a grant or award ($8.33K)
27 Jan 2026	REGISTRATION STATEMENT

Comments